Scroll Top



Hearing loss is the most prevalent sensory dysfunction in humans and recognised as major health, societal and economic burden and an area of unmet medical need. Recent scientific breakthroughs supported by growing private and public investments have facilitated a pipeline of novel hearing therapeutics, ranging from small molecule drugs to gene and cell therapies. As these therapeutics are advancing towards the clinical trial domain, specialist input to deliver proof of concept and to test safety and efficacy has become a priority to both scientists and industry.

Who we are

ENT Clinical is the academic clinical research organisation with the know-how and expertise to support your clinical development program in the hearing field. We do so by combining our clinical expertise and operational quality with specialist knowledge of the translational and patient pathways in hearing disorders, resulting in credible, creative, cost-effective solutions for clinical trials. ENT Clinical is embedded within Julius Clinical, an international science CRO with a long tradition of academic and operational excellence.

What we offer

ENT Clinical offers unique clinical trials expertise and services in ENT, Hearing and Balance disorders and a well-established international network of scientists and clinicians committed to the translation of hearing discoveries into treatments for patients.

Our network

ENT Clinical brings together expert insight in the latest developments in translational hearing research with excellence in clinical trial operations to effectively support your clinical development program. Our global and committed network of clinical academic leaders, guarantees access to expert sites and patient populations across the world.